Ernexa Therapeutics Inc. (ERNA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 7M 14M 21M FY19: 19.8M FY20: 5.8M FY22: 0 FY23: 68K FY24: 582K FY19 FY20 FY22 FY23 FY24

Gross Profit Annual

-200K 0 200K 400K 600K FY22: 0 FY23: -168K FY24: 486K FY22 FY23 FY24

Operating Income Annual

-120M -80M -40M 0 40M 80M 120M FY21: -113.7M FY22: -33.2M FY23: -21.1M FY24: -15.7M FY25: -9.3M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-150M -100M -50M 0 50M 100M 150M FY21: -122.5M FY22: -24.6M FY23: -21.7M FY24: -44.5M FY25: -14.1M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 90K 180K 270K FY22: 0 FY23: 236K FY24: 96K FY22 FY23 FY24

Operating Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY21: -23.5M FY22: -21M FY23: -20.4M FY24: -15.8M FY25: -7M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-27M -18M -9M 0 9M 18M 27M FY21: -23.6M FY22: -21.3M FY23: -20.4M FY24: -16.2M FY25: -7.1M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 2.5M 5M 7.5M FY21: 2.2M FY22: 3.1M FY23: 5.3M FY24: 910K FY25: 6.3M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-120.00 -80.00 -40.00 0.00 40.00 80.00 120.00 Q4 '19: -0.71 Q1 '20: -0.66 Q2 '20: -0.75 Q3 '20: -0.74 Q4 '20: -0.41 Q1 '22: -37.59 Q2 '22: -38.51 Q3 '22: -6.97 Q4 '22: -8.17 Q1 '23: -5.73 Q2 '23: -5.42 Q3 '23: -3.96 Q4 '23: -4.08 Q1 '24: -4.25 Q2 '24: -18.74 Q3 '24: -91.41 Q4 '24: -48.96 Q1 '25: -105.49 Q2 '25: -105.34 Q3 '25: -31.79 Q1 '20 Q4 '20 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.